Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded
- Contract number
- SPE2DR25D3943
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 398 $245,579 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $245,579 Current and potential, with all options
- Last date to order 14% complete
- IDV ceiling <1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract has a ceiling value of $999,999,999 and a period of performance through December 31, 2036. It serves as a prime vendor arrangement to provide worldwide pharmaceutical support, including brand-name and generic drugs, specialty medications, vaccines, medical devices, and other related products, to the Department of Defense (DoD), United States Coast Guard, and other designated government agencies and healthcare programs. The procurement is an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation, and the DLA intends to make multiple primary supplier awards across different geographic regions as well as a separate backup supplier award. The IDC supports normal day-to-day operations as well as contingency, readiness, and war materiel requirements for military treatment facilities, veterans' healthcare, and other federal medical institutions globally.
The original solicitation, which is expected to be issued in March 2024, has an estimated total value of $30.3 billion over the base 30-month period and three 30-month option periods. The contract will cover pharmaceutical products listed in the 6505 stock catalog/schedule and the National Drug Code (NDC) database. Offerors will provide separate distribution fees for brand/generic and specialty drugs, and the DLA may utilize a reverse auction strategy to obtain the best possible pricing. This IDC serves as a critical mechanism for the federal government to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other eligible beneficiaries worldwide.
Task orders
Show 40 more
Latest 50 of 398 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3943?
SPE2DR25D3943 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 24, 2025.
How much is contract SPE2DR25D3943 worth?
Orders under SPE2DR25D3943 have obligated $245,579. SPE2DR25D3943's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D3943?
398 orders have been placed under SPE2DR25D3943, the latest on July 29, 2026.
Who can order from contract SPE2DR25D3943?
SPE2DR25D3943 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3943 competed?
The extent of competition for SPE2DR25D3943 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV